higher bleeding risk seen in j&j, bayer clot drug
a blood clot preventer from johnson &amp; johnson and bayer caused a surprisingly high rate of bleeding in a trial of patients with acute illnesses, representing a setback for the drugmakers.
http://feeds.reuters.com/~r/reuters/healthnews/~3/bpgitsdwicg/us-heart-rivaroxaban-idustre7343cv20110405
21889
05 Apr 2011 23:30:01
reuters
health